Indraprastha Medical Corporation has filed its annual report for the financial year ended March 31, 2026, along with the notice for its 38th Annual General Meeting (AGM). The company also proposed a dividend of ₹4.00 per share for FY26.

The AGM is scheduled for September 24, 2026. The filing includes the Business Responsibility and Sustainability Report for the financial year 2025-26. These documents are available on the company's website.

Dividend Details

The board proposed a dividend of ₹4.00 per equity share, representing 40% of the ₹10 face value. This payout is subject to approval by shareholders at the upcoming AGM.

Eligible shareholders include beneficial owners in demat form as per NSDL and CDSL data, and physical shareholders after valid transmission requests are processed by the close of business on the record date.

Voting Eligibility

The cut-off date to determine eligibility for voting or attending the AGM is fixed as Friday, September 18, 2026. This aligns with the record date for the dividend declaration. Shareholders holding shares as of this date will be eligible to vote on resolutions.

Indraprastha Medical Corporation reported a net profit of ₹55.85 crore for the quarter ended June 30, 2026, reflecting steady growth in its healthcare operations. The result represents an improvement over the ₹51.46 crore net profit recorded in the same quarter of the previous fiscal year. Total income from operations rose to ₹414.57 crore, compared to ₹371.96 crore in Q1FY25, indicating expanded service delivery and patient footfall at its facilities in New Delhi.

The company filed its unaudited financial results with the stock exchanges on August 6, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were approved by the Board of Directors and signed off by Managing Director Shivakumar Pattabhiraman. The full format of the financial statements is available on the company’s website and the respective exchange portals.

The rise in net profit was supported by a consistent expansion in top-line revenue, which grew by approximately 11.5% year-on-year. This growth trajectory suggests effective utilization of existing infrastructure and potential increases in average revenue per patient. The pre-tax profit stood at ₹74.82 crore, up from ₹68.31 crore in the prior year quarter, demonstrating improved operational efficiency before tax provisions.

What the Numbers Show

The proportional growth in both revenue and net profit indicates that Indraprastha Medical Corporation maintained stable operating margins during the quarter. With earnings per share increasing to ₹6.09 from ₹5.61 in the same period last year, shareholders benefited directly from the operational gains. The total comprehensive income for the period was ₹58.10 crore, slightly higher than the net profit due to other comprehensive income items, reflecting a balanced financial performance without significant non-operational volatility.